Health Catalyst Inc (NASDAQ:HCAT)
3.95 USD
-0.030 0.754%Sponsored Reports
Previous Close (in USD) | 3.98 |
---|---|
Change | -0.030 0.754% |
52 W H/L (in USD) | 14.370/5.445 |
EBITDA (in USD) | -51.176M |
PE Ratio | -- |
Volume | 144228 |
Diluted Eps TTM | -1.87 |
Total Assets (in USD) | 701.814M |
---|---|
Total Liabilities (in USD) | 334.895M |
Revenue TTM (in USD) | 296.793M |
Cash (in USD) | 106.276M |
Market Cap (in USD) | 403.208 M |
Revenue Per Share TTM | 5.189 |
Gross Profit TTM (in USD) | 135.561M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Health Catalyst Inc
10897 South River Front Parkway, South Jordan, UT, United States, 84095
801 708 6800
Employees: 1300
Key Executives
Sr. No. | Name | Title | Year Born |
---|---|---|---|
1. | Mr. Daniel D. Burton | CEO & Director | 1975 |
2. | Mr. Bryan Truman Hunt | Chief Financial Officer | 1987 |
3. | Mr. Paul Horstmeier | Chief Operating Officer | 1961 |
4. | Mr. Daniel H. Orenstein | Gen. Counsel & Sec. | 1970 |
5. | Mr. J. Patrick Nelli Jr. | Sr. Advisor | NA |
6. | Mr. Jason Alger | Chief Accounting Officer | 1984 |
7. | Mr. Dave Ross | Chief Technology Officer | NA |
8. | Mr. Jason Jones | Chief Analytics & Data Science Officer and GM of Data & Analytics Platform | NA |
9. | Mr. Adam Brown | Sr. VP of Investor Relations and Financial Planning & Analysis | NA |
10. | Mr. Kyle J. Salyers | Sr. VP of Corp. Devel. | NA |
Peers
Sector: Healthcare
Industry: Health Information Services
Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
GEHC
GE HealthCare Technologies Inc. |
-0.525 0.718% | 72.19 | 22.910 | 20.121 | 2.014 | 5.519 | 2.390 | 13.304 |
VEEV
Veeva Systems Inc Class A |
+3.345 1.186% | 278.27 | 54.610 | 33.223 | 12.830 | 6.727 | 11.138 | 58.844 |
MTHRF
M3 Inc |
0.000 0.000% | 13.65 | 29.720 | 25.000 | 0.046 | 4.379 | 0.041 | 0.118 |
MTHRY
M3 Inc |
-0.150 2.122% | 6.94 | 31.840 | 26.247 | 0.047 | 4.597 | 0.041 | 0.118 |
Income Statement
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Income Before Tax | -141.683M | -160.108M | -116.211M | -59.954M | -62.119M |
Minority Interest | - | - | - | - | 0M |
Net Income | -137.403M | -153.21M | -115.017M | -60.096M | -61.984M |
Selling General Administrative | 61.701M | 85.934M | 59.24M | 31.713M | 22.69M |
Gross Profit | 133.187M | 117.572M | 90.768M | 79.596M | 52.722M |
Reconciled Depreciation | 48.297M | 37.528M | 18.725M | 9.212M | 7.412M |
Ebit | -140.005M | -143.65M | -96.125M | -54.865M | -59.532M |
Ebitda | -91.708M | -106.122M | -77.4M | -45.653M | -52.12M |
Depreciation And Amortization | 48.297M | 37.528M | 18.725M | 9.212M | 7.412M |
Operating Income | -140.005M | -143.65M | -96.125M | -54.865M | -60.095M |
Other Operating Expenses | 416.241M | 385.576M | 284.97M | 209.806M | 172.669M |
Interest Expense | 1.678M | 16.458M | 11.572M | 3.419M | 2.587M |
Tax Provision | -4.28M | -6.898M | -1.194M | 0.142M | -0.135M |
Interest Income | 5.687M | 0.831M | 2.094M | 2.81M | 0.602M |
Net Interest Income | -1.552M | -16.482M | -11.622M | -3.451M | -1.985M |
Income Tax Expense | -4.28M | -6.898M | -1.194M | 0.142M | -0.135M |
Total Revenue | 276.236M | 241.926M | 188.845M | 154.941M | 112.574M |
Total Operating Expenses | 273.192M | 261.222M | 186.893M | 134.461M | 112.817M |
Cost Of Revenue | 143.049M | 124.354M | 98.077M | 75.345M | 59.852M |
Total Other Income Expense Net | -1.678M | -16.458M | -20.086M | -5.089M | -0.039M |
Net Income From Continuing Ops | -137.403M | -153.21M | -115.017M | -60.096M | -61.984M |
Net Income Applicable To Common Shares | -137.403M | -153.21M | -115.017M | -240.922M | -114.021M |
Balance Sheet
(Currency in USD)Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
---|---|---|---|---|---|
Total Assets | 701.814M | 752.286M | 832.096M | 577.74M | 302.36M |
Intangible Assets | 73.384M | 92.189M | 104.788M | 98.921M | 25.535M |
Other Current Assets | 12.279M | 16.335M | 14.609M | 10.632M | 8.392M |
Total Liab | 334.895M | 327.276M | 309.998M | 301.641M | 101.716M |
Total Stockholder Equity | 366.919M | 425.01M | 522.098M | 276.099M | 200.644M |
Other Current Liab | 23.282M | 19.691M | 28.301M | 32.937M | 11.136M |
Common Stock | 1484.056M | 1424.681M | 0.053M | 0.043M | 0.037M |
Capital Stock | 1484.056M | 1424.681M | 0.053M | 0.043M | 0.037M |
Retained Earnings | -1117.17M | -999.023M | -878.86M | -725.65M | -610.514M |
Good Will | 190.652M | 185.982M | 169.972M | 107.822M | 3.694M |
Other Assets | 0M | 3.734M | 4.496M | 28.335M | 0.81M |
Cash | 106.276M | 116.312M | 193.227M | 91.954M | 18.032M |
Cash And Equivalents | - | - | - | - | - |
Total Current Liabilities | 89.034M | 82.51M | 93.051M | 88.036M | 48.217M |
Current Deferred Revenue | 55.753M | 54.961M | 56.632M | 47.145M | 30.653M |
Net Debt | 142.792M | 131.662M | 11.384M | 103.331M | 34.628M |
Short Term Debt | 3.358M | 3.434M | 3.425M | 2.622M | 2.806M |
Short Long Term Debt | - | - | - | - | - |
Short Long Term Debt Total | 249.068M | 247.974M | 204.611M | 195.285M | 52.66M |
Other Stockholder Equity | - | -0.648M | 1400.972M | 1001.645M | 508.689M |
Property Plant Equipment | - | 42.586M | 44.449M | 12.863M | 8.082M |
Total Current Assets | 391.197M | 427.795M | 508.391M | 329.799M | 264.239M |
Long Term Investments | - | - | - | - | - |
Short Term Investments | 211.452M | 247.178M | 251.754M | 178.917M | 210.245M |
Net Receivables | 61.19M | 47.97M | 48.801M | 48.296M | 27.57M |
Long Term Debt | 228.034M | 226.523M | 180.942M | 168.994M | 48.2M |
Inventory | 0M | - | - | - | - |
Accounts Payable | 6.641M | 4.424M | 4.693M | 5.332M | 3.622M |
Accumulated Other Comprehensive Income | 0.033M | -0.648M | -0.067M | 0.061M | 0.072M |
Non Currrent Assets Other | 6.942M | 3.734M | 4.496M | 3.606M | 0.81M |
Non Current Assets Total | 310.617M | 324.491M | 323.705M | 247.941M | 38.121M |
Capital Lease Obligations | 21.034M | 21.451M | 23.669M | 26.291M | 4.46M |
Long Term Debt Total | - | - | - | - | 48.2M |
Cash Flow
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Investments | -39.021M | -74.47M | 29.543M | -205.33M | 23.877M |
Total Cashflows From Investing Activities | -39.021M | -139.678M | -82.565M | -209.602M | 21.403M |
Total Cash From Financing Activities | -2.613M | 264.084M | 182.609M | 231.381M | 24.346M |
Net Income | -137.403M | -153.21M | -115.017M | -60.096M | -61.984M |
Change In Cash | -76.915M | 101.273M | 73.922M | -10.399M | 5.453M |
Begin Period Cash Flow | 193.227M | 91.954M | 18.032M | 28.431M | 22.978M |
End Period Cash Flow | 116.312M | 193.227M | 91.954M | 18.032M | 28.431M |
Total Cash From Operating Activities | -35.27M | -23.123M | -26.148M | -32.184M | -40.296M |
Depreciation | 48.297M | 37.528M | 18.725M | 9.212M | 7.412M |
Other Cashflows From Investing Activities | - | -54.758M | -104.333M | -205.268M | 23.906M |
Dividends Paid | - | - | - | - | 0M |
Change To Inventory | - | -8.325M | -7.081M | -3.653M | 2.465M |
Sale Purchase Of Stock | -8.393M | 270.374M | 40.537M | 0M | -8.712M |
Other Cashflows From Financing Activities | 1.811M | 18.904M | 239.652M | 58.553M | 33.058M |
Capital Expenditures | 17.414M | 18.467M | 10.465M | 4.334M | 2.503M |
Change In Working Capital | -13.907M | 4.616M | -3.827M | -1.266M | 9.751M |
Other Non Cash Items | 0.162M | 29.932M | 37.287M | 2.082M | 0.533M |
Free Cash Flow | -52.684M | -41.59M | -36.613M | -36.518M | -42.799M |
Funds
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | PRIMECAP Odyssey Aggressive Growth | 1 year ago | 1776960 |
2. | Impax US Small Cap Strategy Composite | 1 year ago | 1754475 |
3. | Impax Small Cap Institutional | 1 year ago | 1754475 |
4. | Vanguard Total Stock Mkt Idx Inv | 1 year ago | 1628815 |
5. | iShares Russell 2000 ETF | 1 year ago | 1323931 |
6. | Vanguard Institutional Extnd Mkt Idx Tr | 1 year ago | 878213 |
7. | apo Digital Health Aktien Fonds I | 1 year ago | 773880 |
8. | Nomura ACI AdvMed Impact Inv MF | 1 year ago | 607636 |
9. | Kennedy Extended Small Cap | 1 year ago | 585676 |
10. | Fidelity Small Cap Index | 1 year ago | 581037 |
11. | American Beacon Small Cp Val R5 | 1 year ago | 454542 |
12. | Vanguard Strategic Equity Inv | 1 year ago | 437940 |
13. | BNY Mellon Small Cap Multi-Strategy M | 1 year ago | 435879 |
14. | Nuveen Quant Small Cap Equity R6 | 1 year ago | 423820 |
15. | BBH Partner Fund Small Cap Equity | 1 year ago | 400000 |
16. | Goldman Sachs Small Cap Value A | 1 year ago | 398662 |
17. | Schroder Global Healthcare A Acc | 1 year ago | 379658 |
18. | DFA US Targeted Value I | 1 year ago | 373445 |
19. | Vanguard Strategic Small-Cap Equity Inv | 1 year ago | 348202 |
20. | State St Russell Sm/Mid Cp® Indx NL Cl C | 1 year ago | 346997 |
Institutions
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | BlackRock Inc | 1 year ago | 5318571 |
2. | Vanguard Group Inc | 1 year ago | 4476231 |
3. | Wellington Management Company LLP | 1 year ago | 3140282 |
4. | Goldman Sachs Group Inc | 1 year ago | 2441254 |
5. | Daventry Group, LP | 1 year ago | 2162875 |
6. | Impax Asset Management Group PLC | 1 year ago | 2154475 |
7. | PRIMECAP Management Company | 1 year ago | 2074383 |
8. | Dimensional Fund Advisors, Inc. | 1 year ago | 1629193 |
9. | State Street Corporation | 1 year ago | 1287532 |
10. | Geode Capital Management, LLC | 1 year ago | 1260668 |
11. | Granahan Investment Management Inc.. | 1 year ago | 1233721 |
12. | Millennium Management LLC | 1 year ago | 1229149 |
13. | Bank of New York Mellon Corp | 1 year ago | 1218288 |
14. | Nepsis, Inc. | 1 year ago | 1157394 |
15. | JPMorgan Chase & Co | 1 year ago | 1090849 |
16. | First Light Asset Management, LLC | 1 year ago | 1014475 |
17. | Nuveen Asset Management, LLC | 1 year ago | 772728 |
18. | Jacobs Levy Equity Management, Inc. | 1 year ago | 738501 |
19. | Acadian Asset Management LLC | 1 year ago | 724560 |
20. | Morgan Stanley - Brokerage Accounts | 1 year ago | 686664 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).